Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Downgraded by Wall Street Zen to “Hold”

Wall Street Zen cut shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) from a buy rating to a hold rating in a report published on Saturday morning.

BAYRY has been the topic of a number of other reports. Kepler Capital Markets raised Bayer Aktiengesellschaft from a “hold” rating to a “buy” rating in a report on Wednesday, June 11th. Hsbc Global Res raised Bayer Aktiengesellschaft from a “hold” rating to a “strong-buy” rating in a report on Wednesday, June 11th. Finally, The Goldman Sachs Group raised Bayer Aktiengesellschaft from a “hold” rating to a “strong-buy” rating in a report on Thursday, June 5th. Two equities research analysts have rated the stock with a hold rating, one has assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Bayer Aktiengesellschaft currently has an average rating of “Buy”.

Bayer Aktiengesellschaft Stock Up 0.5%

OTCMKTS:BAYRY opened at $7.91 on Friday. The firm has a market capitalization of $31.08 billion, a price-to-earnings ratio of -30.42 and a beta of 0.85. Bayer Aktiengesellschaft has a twelve month low of $4.79 and a twelve month high of $8.58. The stock’s 50 day moving average price is $6.72 and its two-hundred day moving average price is $5.99. The company has a quick ratio of 0.81, a current ratio of 1.32 and a debt-to-equity ratio of 1.19.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last posted its quarterly earnings results on Tuesday, May 13th. The company reported $0.65 earnings per share for the quarter, topping the consensus estimate of $0.63 by $0.02. The firm had revenue of $15.27 billion for the quarter, compared to analyst estimates of $13.39 billion. Bayer Aktiengesellschaft had a positive return on equity of 16.90% and a negative net margin of 2.02%. Equities research analysts expect that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current fiscal year.

Bayer Aktiengesellschaft Increases Dividend

The firm also recently announced a dividend, which was paid on Monday, May 12th. Investors of record on Wednesday, April 30th were issued a dividend of $0.0224 per share. The ex-dividend date of this dividend was Tuesday, April 29th. This is a positive change from Bayer Aktiengesellschaft’s previous dividend of $0.02. This represents a dividend yield of 0.38%. Bayer Aktiengesellschaft’s payout ratio is presently -2.17%.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.